Medicine & Health

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.

Biomedical researchers at Washington University have decoded how mechanical forces drive cell behavior in fibrosis.

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.

Jessica Backman-Levy (left), at the Brown School, and Beryne Odeny, MD, PhD, at the School of Medicine, have been selected to participate in a yearlong program aimed at advancing women into senior leadership positions in global health.

The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.

Rob Bilott, the attorney who exposed DuPont’s water contamination cover-up, will speak April 7 for the Assembly Series. “Dark Waters,” a film based on his fight for justice, screens in advance.

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.

About 55 high school students from the St. Louis region and beyond tested their knowledge of the human brain and learned about neuroscience careers at the 15th annual St. Louis Area Brain Bee March 8 at Washington University in St. Louis.